EGFR and neoplasm: The epidermal growth factor receptor (EGFR) binds to and phosphorylates Y393-AGO2 in response to hypoxia, reducing the interaction between AGO2 and DICER and inhibiting the processing of tumor-suppressing miRNAs [76].